[Use of sordinol in mental disordes of vascular origin].
D000328:Adult; D000368:Aged; D002561:Cerebrovascular Disorders / Q000150:complications* / Q000503:physiopathology; D003006:Clopenthixol / Q000627:therapeutic use; D003693:Delirium / Q000188:drug therapy; D003863:Depression / Q000188:drug therapy; D005260:Female; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000150:complications; D008297:Male; D008875:Middle Aged; D019965:Neurocognitive Disorders / Q000188:drug therapy* / Q000209:etiology; D010259:Paranoid Disorders / Q000188:drug therapy; D010879:Piperazines / Q000627:therapeutic use*; D010992:Plethysmography, Impedance; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D010879:Piperazines; D014149:Tranquilizing Agents; D003006:Clopenthixol
Primenenie sordinola pri psikhicheskikh narusheniiakh sosudistogo geneza.